- Home
- ATUS vs SYRE Comparison
ATUS vs SYRE Comparison
Compare ATUS & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATUS
- SYRE
- Stock Information
- Founded
- ATUS 2015
- SYRE 2013
- Country
- ATUS United States
- SYRE United States
- Employees
- ATUS N/A
- SYRE N/A
- Industry
- ATUS Cable & Other Pay Television Services
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- ATUS Telecommunications
- SYRE Health Care
- Exchange
- ATUS Nasdaq
- SYRE Nasdaq
- Market Cap
- ATUS 1.2B
- SYRE 841.4M
- IPO Year
- ATUS 2017
- SYRE 2016
- Fundamental
- Price
- ATUS $2.76
- SYRE $12.86
- Analyst Decision
- ATUS Buy
- SYRE Buy
- Analyst Count
- ATUS 6
- SYRE 8
- Target Price
- ATUS $2.67
- SYRE $50.00
- AVG Volume (30 Days)
- ATUS 3.9M
- SYRE 570.5K
- Earning Date
- ATUS 05-08-2025
- SYRE 05-20-2025
- Dividend Yield
- ATUS N/A
- SYRE N/A
- EPS Growth
- ATUS N/A
- SYRE N/A
- EPS
- ATUS N/A
- SYRE N/A
- Revenue
- ATUS $8,855,764,000.00
- SYRE N/A
- Revenue This Year
- ATUS N/A
- SYRE N/A
- Revenue Next Year
- ATUS N/A
- SYRE N/A
- P/E Ratio
- ATUS N/A
- SYRE N/A
- Revenue Growth
- ATUS N/A
- SYRE N/A
- 52 Week Low
- ATUS $1.52
- SYRE $10.91
- 52 Week High
- ATUS $3.20
- SYRE $40.49
- Technical
- Relative Strength Index (RSI)
- ATUS 64.76
- SYRE 40.40
- Support Level
- ATUS $2.37
- SYRE $14.48
- Resistance Level
- ATUS $2.60
- SYRE $15.77
- Average True Range (ATR)
- ATUS 0.15
- SYRE 1.02
- MACD
- ATUS 0.05
- SYRE 0.03
- Stochastic Oscillator
- ATUS 94.26
- SYRE 16.50
About ATUS Altice USA Inc.
Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and business in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York and i24News, a news operation focused on the Middle East.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.